Oct 20, 202627 min
During the latest AML Hub Steering Committee Meeting on August 11, 2026, key opinion leaders met to discuss the role of combination strategies in the treatment of FLT3 -mutated ( FLT3 m) acute myeloid leukemia (AML)...
education
AML Hub
Hosted by Scientific Education Support · education · EN
About this Podcast:
The AML Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
32%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for AML Hub.
Signup to Generate a PitchQuestions about AML Hub
What is AML Hub about?
The AML Hub is an open-access online resource dedicated to providing balanced, credible, and up-to-date medical education on acute myeloid leukemia (AML). Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management.
Who hosts AML Hub?
AML Hub is hosted by Scientific Education Support. The show has published 45 episodes to date.
What has AML Hub covered recently?
Recent episodes include "The role of combination strategies in the treatment of FLT3-mutated acute myeloid leukemia" (20 October 2026, 27 minutes), "Targeting menin: A paradigm shift in acute myeloid leukemia therapy" (13 October 2026, 34 minutes), and "FLT3 inhibitors in AML: Current clinical landscape and key insights from trials" (1 July 2026, 5 minutes).
How often does AML Hub publish?
AML Hub publishes roughly weekly, with episodes averaging 14 minutes across 45 episodes.
How hard is it to get booked on AML Hub?
Booking probability for AML Hub is 32%, and the host is rated Selective on guests. AML Hub requires a Pod Score of 80 or higher. AML Hub's contact route on record: verified email.
Who should pitch AML Hub?
The strongest fits for AML Hub are Health & Wellness Services. AML Hub has an education audience.
About the host
Scientific Education Support hosts AML Hub, an education podcast with 45 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
- Oct 13, 202634 min
Steering committee meeting In August, 2026, the AML Hub held a steering committee meeting where Joshua Zeidner presented on Targeting menin: A paradigm shift in acute myeloid leukemia therapy, followed by a panel...
- Jul 1, 20265 min
The AML Hub was pleased to speak with Mark J. Levis, Johns Hopkins University, Baltimore, US. We asked, What is the current clinical landscape of FLT3 inhibitors in the treatment of AML, and what insights have been...
- Jun 30, 20264 min
The AML Hub was pleased to speak with Eytan Stein, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What might the future hold for the evolution of FLT3 inhibitors in the treatment of AML? Stein...
- Jun 26, 20265 min
The AML Hub was pleased to speak with Charles Craddock, Queen Elizabeth Hospital Birmingham, Birmingham, UK. We asked, What are the key ongoing questions in FLT3-mutated AML, and how are ongoing trials addressing these...
View More
- May 22, 202630 min
During a meeting of the AML Hub Steering Committee, held on February 19, 2026, Jorge Cortes chaired a discussion on the topic, Menin inhibitors in AML: Where are we now, and where are we going? The discussion featured...
- May 21, 20268 min
The AML Hub was pleased to speak with Gail Roboz, Weill Cornell Medicine, New York, US. We asked, What side effects are typically observed with menin inhibitor-based regimens, and how do you approach managing them in...
- May 20, 20264 min
The AML Hub was pleased to speak with Eunice Wang from Roswell Park Comprehensive Cancer Center, Buffalo, US. We asked, What are the mechanisms and rationale for menin inhibitor combination strategies? Wang summarizes...
- May 19, 202633 min
During a meeting of the AML Hub Steering Committee, held on February 19, 2026, Jorge Sierra chaired a discussion on the topic, Treatment decisions in acute myeloid leukemia (AML): Personalizing care with FLT3 inhibitor...
AML Hub
What key insights are emerging from ongoing trials of menin inhibitor combination strategies in AML?
May 15, 20265 minThe AML Hub was pleased to speak with Joshua Zeidner, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, US. We asked, What key insights are emerging from ongoing trials of menin inhibitor...
- Feb 12, 20267 min
The AML Hub held a virtual symposium on November 19, 2025, titled Understanding the differences between FLT3 -ITD and -TKD mutations in AML: Implications for clinical...
AML Hub
Symposium | Implications for clinical practice: Managing AML with FLT3-ITD and -TKD mutations
Feb 11, 202614 minThe AML Hub held a virtual symposium on November 19, 2025, titled Understanding the differences between FLT3 -ITD and -TKD mutations in AML: Implications for clinical practice. Here, we share a presentation from the...
- Jan 19, 202620 min
The AML Hub held a webinar on November 19, 2025, titled, Understanding the differences between FLT3-ITD and -TKD mutations in AML: Implications for clinical practice. Here, we share a presentation from the webinar by...
- Jan 14, 202617 min
The AML Hub held a webinar on November 19, 2025, titled, “Understanding the differences between FLT3-ITD and -TKD mutations in AML: Implications for clinical practice.” Here, we share one of the presentations, by Jorge...
- Jan 13, 20268 min
Following the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, December 6–9, 2025, Orlando, US, the AML Hub was pleased to speak with Gail Roboz, Weill Cornell Medicine, New York, US. We asked...
AML Hub
ASH 2025 | PARADIGM: Azacitidine + venetoclax vs conventional induction in fit adults with ND AML
Dec 18, 20257 minFollowing the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, December 6–9, 2025, Orlando, US, the AML Hub was pleased to speak with Amir Fathi, Massachusetts General Hospital, Boston, US. We...
- Nov 6, 20255 min
The AML Hub was pleased to speak with Eytan Stein, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What are the latest data presented on current and emerging treatments for acute myeloid leukemia (AML)...
- Oct 24, 20257 min
The AML Hub was pleased to speak with Emma Searle, The Christie NHS Foundation Trust, Manchester, UK. We asked for her thoughts on the topic “Menin inhibitors in AML: Bridging the gap between trial data and clinical...
- Sep 22, 202523 min
During a meeting of the AML Hub Steering Committee, held on July 22, 2025, Charles Craddock chaired a discussion on the topic: Addressing uncertainty in patient selection for transplant. The discussion featured...
- Sep 3, 20256 min
The AML Hub was pleased to speak with Joshua Zeidner, Associate Professor of Medicine at the University of North Carolina Lineberger Comprehensive Cancer Center in Durham, North Carolina. We asked for his thoughts on...
Recent guests
Recent guests on AML Hub. Study who booked and why before you pitch.
C
Courtney DiNardo
Professor of Medicine, Department of Leukemia, MD Anderson Cancer Center
G
Gail J.. Roboz
Weill Cornell Medicine
J
Jorge Cortes
Georgia Cancer Center
J
Joshua Zeidner
University of North Carolina Lineberger Comprehensive Cancer Center
Best industries to pitch AML Hub for
PitchCentric classifies AML Hub under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like AML Hub
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ